Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US-9220820-B2 · Dec 29, 2015 · US
US10967103B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10967103-B2 |
| Application number | US-201716073017-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 3, 2017 |
| Priority date | Feb 3, 2016 |
| Publication date | Apr 6, 2021 |
| Grant date | Apr 6, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to self-assembled organosilane coatings for resorbable medical implant devices. The coatings can be prepared from coating compositions containing organosilane and can be applied to metal or metal alloy substrates. Prior to applying the coatings, the surfaces of the substrates can be pretreated. The coatings can be functionalized with a binding compound that is coupled with an active component. The coatings can be selectively removed, e.g., patterned, to expose portions of the uncoated substrate. Selecting different patterns can provide the ability to regulate or control various properties, such as, corrosion and hydrogen generation.
Opening claim text (preview).
We claim: 1. A medical implant device, comprising: a substrate selected from the group consisting of magnesium and magnesium alloy, having a first surface and an opposing second surface; a thin film coating applied to at least one of the first and second surfaces, comprising: a self-assembled amphiphilic organosilane having a hydrophobic aliphatic tail containing a C 4 to C 20 backbone, and a hydrophilic silane head reactive with the substrate, comprising: an alkyltrialkoxy silane tetramethoxysilane co-polymer; a cross-linking agent combined with the co-polymer; and an aminosilane binding compound; and a pattern applied to the thin film coating in a form such that one or more selected areas of the substrate is uncoated. 2. The medical implant device of claim 1 , wherein the aminosilane binding compound is aminopropyl-trimethoxy silane. 3. The medical implant device of claim 1 , further comprising an active component coupled to the binding compound. 4. The medical implant device of claim 1 , further comprising a pretreatment applied to at least one of the first and second surfaces, and the coating applied to the pretreatment. 5. The medical implant device of claim 1 , wherein a first portion of the pattern has a first configuration and a second portion of the pattern has a different, second configuration. 6. The medical implant device of claim 1 , wherein the one or more selected areas that are uncoated is effective to increase the corrosion rate of the substrate. 7. The medical implant device of claim 1 , wherein a laminar structure of the thin film coating has multiple layers.
After-treatment · CPC title
Post-treatment of applied coatings · CPC title
by exposure to radiation (B05D3/02 takes precedence {; plasma treatment B05D3/141}) · CPC title
Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06 · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.